Let's Talk About This

Altering the human germline through genome editing needs further ethical discussion by the scientific community, the White House says.

"The Administration believes that altering the human germline for clinical purposes is a line that should not be crossed at this time," writes John Holdren, the director of the White House Office of Science and Technology Policy, in a blog post.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Technology Review reports that researchers in the US have used CRISPR to modify a number of human embryos.

By introducing genes from butterfly peas and Canterbury bells, researchers in Japan have developed a blue chrysanthemum, according to NPR.

Plant researchers plan to sequence some 10,000 samples that represent the major plant clades, ScienceInsider reports.

In Nature this week: a Danish reference genome, and more.